DB
VIR icon

Dmitry Balyasny’s Vir Biotechnology VIR Stock Holding History

Dmitry Balyasny’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,368,474
Closed -$8.25M – 3583
2025
Q4 		$8.25M Buy
+1,368,474
New +$8.15M 0.01% 1121
2025
Q2 		– Sell
-266,005
Closed -$1.72M – 3394
2025
Q1 		$1.72M Buy
266,005
+209,221
+368% +$1.86M ﹤0.01% 1770
2024
Q4 		$417K Buy
56,784
+30,351
+115% +$239K ﹤0.01% 2258
2024
Q3 		$198K Buy
+26,433
New +$230K ﹤0.01% 2571
2023
Q4 		– Sell
-235,604
Closed -$2.21M – 2941
2023
Q3 		$2.21M Sell
235,604
-283,248
-55% -$4.04M ﹤0.01% 1355
2023
Q2 		$12.7M Buy
518,852
+115,904
+29% +$2.91M 0.03% 675
2023
Q1 		$9.38M Buy
+402,948
New +$10.3M 0.02% 807
2022
Q4 		– Sell
-385,146
Closed -$7.43M – 3269
2022
Q3 		$7.43M Buy
385,146
+374,897
+3,658% +$9.53M 0.02% 822
2022
Q2 		$261K Buy
+10,249
New +$239K ﹤0.01% 2137
2022
Q1 		– Sell
-218,710
Closed -$9.16M – 2876
2021
Q4 		$9.16M Buy
218,710
+191,899
+716% +$7.52M 0.03% 660
2021
Q3 		$1.17M Buy
26,811
+7,468
+39% +$323K ﹤0.01% 1291
2021
Q2 		$915K Buy
+19,343
New +$879K ﹤0.01% 1327
2020
Q2 		– Sell
-91,977
Closed -$3.15M – 1505
2020
Q1 		$3.15M Buy
+91,977
New +$2.47M 0.04% 514

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GP
GSK plc London $602M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Dmitry Balyasny's VIR Position: Q1 2026 in Review

Dmitry Balyasny sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 1,368,474 shares — an estimated $8.25M sold.

Dmitry Balyasny first reported a position in VIR in Q1 2020 and held it in 13 quarters. The position peaked at $12.7M in Q2 2023. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Dmitry Balyasny reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 1,368,474 Vir Biotechnology shares in Q1 2026, an estimated $8.25M.
  • Dmitry Balyasny first reported a position in Vir Biotechnology in Q1 2020 and held it in 13 quarters.
  • Dmitry Balyasny's Vir Biotechnology position peaked at $12.7M in Q2 2023.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.